BACKGROUND: More than 25% of pediatric kidney transplants are lost within 7 years, necessitating dialysis or retransplantation. Retransplantation practices and the outcomes of repeat transplantations, particularly among those with early graft loss, are not clear. METHODS: We examined retransplantation practice patterns and outcomes in 14,799 pediatric (ages <18 years) patients between 1987 and 2010. Death-censored graft survival was analyzed using extended Cox models and retransplantation using competing risks regression. RESULTS: After the first graft failure, 50.4% underwent retransplantation and 12.1% died within 5 years; after the second graft failure, 36.1% underwent retransplantation and 15.4% died within 5 years. Prior preemptive transplantation and graft loss after 5 years were associated with increased rates of retransplantation. Graft loss before 5 years, older age, non-Caucasian race, public insurance, and increased panel-reactive antibody were associated with decreased rates of retransplantation. First transplants had lower risk of graft loss compared with second (adjusted hazard ratio [aHR], 0.72; 95% confidence interval [CI], 0.64-0.80; P<0.001), third (aHR, 0.62; 95% CI, 0.49-0.78; P<0.001), and fourth (aHR, 0.44; 95% CI, 0.24-0.78; P=0.005) transplants. However, among patients receiving two or more transplants (conditioned on having lost a first transplant), second graft median survival was 8.5 years despite a median survival of 4.5 years for the first transplant. Among patients receiving three or more transplants, third graft median survival was 7.7 years despite median survivals of 2.1 and 3.1 years for the first and second transplants. CONCLUSIONS: Among pediatric kidney transplant recipients who experience graft loss, racial and socioeconomic disparities exist with regard to retransplantation, and excellent graft survival can be achieved with retransplantation despite poor survival of previous grafts.
BACKGROUND: More than 25% of pediatric kidney transplants are lost within 7 years, necessitating dialysis or retransplantation. Retransplantation practices and the outcomes of repeat transplantations, particularly among those with early graft loss, are not clear. METHODS: We examined retransplantation practice patterns and outcomes in 14,799 pediatric (ages <18 years) patients between 1987 and 2010. Death-censored graft survival was analyzed using extended Cox models and retransplantation using competing risks regression. RESULTS: After the first graft failure, 50.4% underwent retransplantation and 12.1% died within 5 years; after the second graft failure, 36.1% underwent retransplantation and 15.4% died within 5 years. Prior preemptive transplantation and graft loss after 5 years were associated with increased rates of retransplantation. Graft loss before 5 years, older age, non-Caucasian race, public insurance, and increased panel-reactive antibody were associated with decreased rates of retransplantation. First transplants had lower risk of graft loss compared with second (adjusted hazard ratio [aHR], 0.72; 95% confidence interval [CI], 0.64-0.80; P<0.001), third (aHR, 0.62; 95% CI, 0.49-0.78; P<0.001), and fourth (aHR, 0.44; 95% CI, 0.24-0.78; P=0.005) transplants. However, among patients receiving two or more transplants (conditioned on having lost a first transplant), second graft median survival was 8.5 years despite a median survival of 4.5 years for the first transplant. Among patients receiving three or more transplants, third graft median survival was 7.7 years despite median survivals of 2.1 and 3.1 years for the first and second transplants. CONCLUSIONS: Among pediatric kidney transplant recipients who experience graft loss, racial and socioeconomic disparities exist with regard to retransplantation, and excellent graft survival can be achieved with retransplantation despite poor survival of previous grafts.
Authors: Allison Tong; Kirsten Howard; Stephen Jan; Alan Cass; John Rose; Steven Chadban; Richard D Allen; Jonathan C Craig Journal: Transplantation Date: 2010-04-15 Impact factor: 4.939
Authors: Lauren M Kucirka; Morgan E Grams; Justin Lessler; Erin Carlyle Hall; Nathan James; Allan B Massie; Robert A Montgomery; Dorry L Segev Journal: JAMA Date: 2011-08-10 Impact factor: 56.272
Authors: Enrique Lledó-García; Carlos Hernández-Fernández; David Subirá-Ríos; José Maria Díez-Cordero; Ramón Durán-Merino; Felipe Herranz-Amo; Fernando Verdú-Tartajo; Mercedes Moralejo-Gárate; Gonzalo Bueno-Chomón; Gabriel Ogaya-Pinies; Dolores Morales; Augusto Luque-de Pablos Journal: J Urol Date: 2011-04-27 Impact factor: 7.450
Authors: Kyle J Van Arendonk; Brian J Boyarsky; Babak J Orandi; Nathan T James; Jodi M Smith; Paul M Colombani; Dorry L Segev Journal: Pediatrics Date: 2014-03-10 Impact factor: 7.124
Authors: Kyle J Van Arendonk; Nathan T James; Babak J Orandi; Jacqueline M Garonzik-Wang; Jodi M Smith; Paul M Colombani; Dorry L Segev Journal: Transplantation Date: 2013-09-15 Impact factor: 4.939
Authors: Kyle J Van Arendonk; Eric K H Chow; Nathan T James; Babak J Orandi; Trevor A Ellison; Jodi M Smith; Paul M Colombani; And Dorry L Segev Journal: Transplantation Date: 2015-02 Impact factor: 4.939
Authors: Meera Gupta; Alexander Wood; Nandita Mitra; Susan L Furth; Peter L Abt; Matthew H Levine Journal: Transplantation Date: 2015-08 Impact factor: 4.939
Authors: Ankit Sharma; Anne Taverniti; Nicole Graf; Armando Teixeira-Pinto; Joshua R Lewis; Wai H Lim; Stephen I Alexander; Anne Durkan; Jonathan C Craig; Germaine Wong Journal: Pediatr Nephrol Date: 2020-02-17 Impact factor: 3.714
Authors: Aesha Maniar; David K Hooper; Christine B Sethna; Pamela Singer; Avram Traum; Elizabeth Benoit; Elizabeth Kotzen; Priya Verghese; Rouba Garro; Margaret Kamel; Daniel Ranch; Weiwen Shih; Namrata G Jain; Samhar Al-Akash Journal: Pediatr Transplant Date: 2021-07-11